Redeye Orphan Drug day

Back to news

Read more posts

Related posts

Patient insights to shape development of a dCBT for IPF patients

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

MedNous article: A surprise finding in the clinic

Untangling the dualistic components of the RAS in PF the Yin and Yang

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic